The coagulopathy in sepsis: significance and implications for treatment

Paola Saracco1, Pasquale Vitale, Carlo Scolfaro

  • 1Hematology Unit, Department of Pediatrics, University of Turin;

Pediatric Reports
|February 23, 2012
PubMed

Insights

Sepsis-associated coagulopathy, including disseminated intravascular coagulation (DIC), impairs microvascular function and predicts outcomes. Strategies targeting coagulation activation or restoring anticoagulation show promise but require further clinical trials.

Area of Science:

  • Coagulation and Thrombosis
  • Critical Care Medicine
  • Sepsis Pathophysiology

Background:

  • Sepsis-induced coagulopathy spans mild alterations to severe disseminated intravascular coagulation (DIC).
  • DIC contributes to microvascular dysfunction and organ failure in sepsis.
  • Coagulation activation consumes platelets and factors, potentially causing bleeding.

Purpose of the Study:

  • To review the role of coagulopathy in sepsis pathogenesis and outcomes.
  • To discuss novel supportive strategies for sepsis-related coagulopathy.
  • To highlight the need for further clinical trials on these strategies.

Main Methods:

  • Literature review of sepsis-associated coagulopathy.
  • Analysis of coagulation pathways involved in sepsis.
  • Discussion of emerging therapeutic interventions.

Main Results:

  • Sepsis-related coagulopathy is an independent predictor of clinical outcome.
  • Enhanced intravascular fibrin deposition results from complex coagulation dysregulation.
  • Potential strategies include inhibiting tissue factor or restoring anticoagulant pathways.

Conclusions:

  • Current evidence suggests DIC is integral to sepsis-induced organ failure.
  • Restoring physiological anticoagulation (e.g., recombinant human activated protein C) warrants investigation.
  • Further clinical trials are essential to establish the efficacy of novel treatments in pediatric and adult sepsis.

Related Concept Videos

Acute Inflammation III: Local and Systemic Effects01:25

Acute Inflammation III: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Coagulation01:06

Coagulation

Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...